PE Ratio
-326.98
₹762.80 -5.15 (-0.67%)
As on October 30, 2026
-9.64%
1 Y CAGR
491
CR
Market Cap
Company profile
Albert David Limited is an Indian pharmaceutical company specializing in the production and distribution of a diverse array of medical products. Its offerings encompass pharmaceutical formulations, intravenous solutions, herbal medicines, bulk drug substances, and disposable medical devices like syringes and needles. The company's formulations address various therapeutic areas, including injectable medications (parenterals), oral and enteral drugs, topical applications, and vision care products. In addition to its operations within India, Albert David Limited actively exports its products to markets across Latin America, Southeast Asia, and different African nations. The company, established in 1938, is headquartered in Kolkata, India.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.22
Dividend Yield
0.58%
Sector PE
42.60
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹3.3KCAGR 5-Year
+1.56%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
